Chemical Marker Reporter October 13, 2015 ferghanaadmin Press Release “SCHERING AG; acquired rights for Refludan” Related Posts BioPartnering Europe (BPE) "Leading lifescience conference announces full event program" Celularity "Alliqua BioMedical Announces Definitive Asset Purchase Agreement with Celularity" Reuters "Venture capitalists plough $1 Billion into Euro Biotech"
